Effect of moxidectin selection on the genetic variation within Cylicocyclus nassatus based on amplified fragment length polymorphism (AFLP).
Cyathostomins are among the most important intestinal nematodes of horses, yet, the literature on the molecular genetics of these worms is scarce. In this study, the technique of amplified fragment length polymorphism (AFLP) was applied to study the genetic diversity as well as to determine the effect of moxidectin selection on the population genetic diversity for Cylicocyclus nassatus, one of the most common cyathostomin species. Genomic DNAs from 30 individual male worms were used from each of two populations: an avermectin-milbemycin (AM)-naive population (Population-S) and a population derived from Population-S following 21 treatments with moxidectin (Population-Mox). Three selective primer pairs were used for each worm, yielding a total of 229 AFLP markers. Calculation of average pair wise Jaccard indices revealed a high degree of genetic variation within both populations using all three primer combinations. In addition, selection by moxidectin during a 3-year period caused a significant decrease in the level of genetic diversity as evidenced by analysis of AFLP markers for two primer combinations but not for the third. A dendrogram of relationships among individuals based on AFLP markers did not show a clear classification of individuals in separate groups. It was concluded that a high degree of genetic intrapopulation variation exists in C. nassatus and that moxidectin selection has a significant effect on the genetic composition of C. nassatus.
Tandon
R
R
Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, USA.
Lyons
E T
ET
Tolliver
S C
SC
Kaplan
R M
RM
D000818:Animals; D000969:Antinematodal Agents / Q000494:pharmacology*; D005819:Genetic Markers; D014644:Genetic Variation; D006736:Horses / Q000469:parasitology; D018942:Macrolides / Q000494:pharmacology; D011110:Polymorphism, Genetic; D019105:Random Amplified Polymorphic DNA Technique; D012641:Selection, Genetic; D013320:Strongyloidea / Q000187:drug effects* / Q000235:genetics*
D000969:Antinematodal Agents; D005819:Genetic Markers; D018942:Macrolides; C027837:moxidectin